Login
Home
Charts
Search
Watchlist
Products

Vascon Engineers Ltd

VASCONEQ·NSE
31.44-2.30%Tue, 22 Sept '26

Vascon Engineers Ltd

VASCONEQ
NSE
31.44
-2.30%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
728Cr
Close
Close Price
31.44
Industry
Industry
Construction & Contracting
PE
Price To Earnings
25.15
PS
Price To Sales
0.83
Revenue
Revenue
880Cr
Rev Gr TTM
Revenue Growth TTM
-20.20%
PAT Gr TTM
PAT Growth TTM
-80.13%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
159207234196200295387221226249253152
Growth YoY
Revenue Growth YoY%
-26.8-18.7-28.7-4.025.542.765.812.712.9-15.4-34.6-31.3
Expenses
ExpensesCr
152186213180185275350208210236242147
Operating Profit
Operating ProfitCr
7212016142038131613115
OPM
OPM%
4.610.08.68.17.26.89.75.97.05.34.23.3
Other Income
Other IncomeCr
171622785214465
Interest Expense
Interest ExpenseCr
343455553626
Depreciation
DepreciationCr
212112221211
PBT
PBTCr
20162112109136271510132
Tax
TaxCr
0063216254170
PAT
PATCr
211917101076352211962
Growth YoY
PAT Growth YoY%
-8.813.7-66.1-19.3-50.1307.2106.7134.110.9-87.7-83.5-91.0
NPM
NPM%
13.09.07.24.95.225.69.010.25.13.72.31.3
EPS
EPS
0.90.80.80.40.53.41.51.00.50.40.30.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
159207234196200295387221226249253152
Growth YoY
Revenue Growth YoY%
-26.8-18.7-28.7-4.025.542.765.812.712.9-15.4-34.6-31.3
Expenses
ExpensesCr
152186213180185275350208210236242147
Operating Profit
Operating ProfitCr
7212016142038131613115
OPM
OPM%
4.610.08.68.17.26.89.75.97.05.34.23.3
Other Income
Other IncomeCr
171622785214465
Interest Expense
Interest ExpenseCr
343455553626
Depreciation
DepreciationCr
212112221211
PBT
PBTCr
20162112109136271510132
Tax
TaxCr
0063216254170
PAT
PATCr
211917101076352211962
Growth YoY
PAT Growth YoY%
-8.813.7-66.1-19.3-50.1307.2106.7134.110.9-87.7-83.5-91.0
NPM
NPM%
13.09.07.24.95.225.69.010.25.13.72.31.3
EPS
EPS
0.90.80.80.40.53.41.51.00.50.40.30.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5884905395245215066571,0197641,077949880
Growth
Revenue Growth%
-5.6-16.610.0-2.8-0.6-2.929.955.2-25.141.1-12.0-20.2
Expenses
ExpensesCr
553497532517467519634902688990897835
Operating Profit
Operating ProfitCr
35-77754-132211776875245
OPM
OPM%
5.9-1.41.21.410.3-2.63.411.59.98.15.55.1
Other Income
Other IncomeCr
275838372012531112873519
Interest Expense
Interest ExpenseCr
383325261927241314191617
Depreciation
DepreciationCr
15161413151211126666
PBT
PBTCr
835440-4040103681496541
Tax
TaxCr
-110-100446231612
PAT
PATCr
915540-403699611264928
Growth
PAT Growth%
106.4-86.9284.413.5653.0-201.4189.2176.8-38.2105.7-61.3-80.1
NPM
NPM%
1.60.30.91.07.6-8.05.59.88.111.75.23.2
EPS
EPS
0.60.10.30.42.2-2.31.84.53.05.82.11.3
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5884905395245215066571,0197641,077949880
Growth
Revenue Growth%
-5.6-16.610.0-2.8-0.6-2.929.955.2-25.141.1-12.0-20.2
Expenses
ExpensesCr
553497532517467519634902688990897835
Operating Profit
Operating ProfitCr
35-77754-132211776875245
OPM
OPM%
5.9-1.41.21.410.3-2.63.411.59.98.15.55.1
Other Income
Other IncomeCr
275838372012531112873519
Interest Expense
Interest ExpenseCr
383325261927241314191617
Depreciation
DepreciationCr
15161413151211126666
PBT
PBTCr
835440-4040103681496541
Tax
TaxCr
-110-100446231612
PAT
PATCr
915540-403699611264928
Growth
PAT Growth%
106.4-86.9284.413.5653.0-201.4189.2176.8-38.2105.7-61.3-80.1
NPM
NPM%
1.60.30.91.07.6-8.05.59.88.111.75.23.2
EPS
EPS
0.60.10.30.42.2-2.31.84.53.05.82.11.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
161168174178178182217217221226232
Reserves
ReservesCr
465467494501541505585684753862914
Current Liabilities
Current LiabilitiesCr
5805095284724955486316486329211,031
Non Current Liabilities
Non Current LiabilitiesCr
133168115159117593577249115182
Total Liabilities
Total LiabilitiesCr
1,3521,3231,3221,3311,3561,3161,4901,6491,8622,1282,361
Current Assets
Current AssetsCr
9009299359851,0151,0011,1771,2701,2581,7392,012
Non Current Assets
Non Current AssetsCr
453394387345341315313380603389350
Total Assets
Total AssetsCr
1,3521,3231,3221,3311,3561,3161,4901,6491,8622,1282,361
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
161168174178178182217217221226232
Reserves
ReservesCr
465467494501541505585684753862914
Current Liabilities
Current LiabilitiesCr
5805095284724955486316486329211,031
Non Current Liabilities
Non Current LiabilitiesCr
133168115159117593577249115182
Total Liabilities
Total LiabilitiesCr
1,3521,3231,3221,3311,3561,3161,4901,6491,8622,1282,361
Current Assets
Current AssetsCr
9009299359851,0151,0011,1771,2701,2581,7392,012
Non Current Assets
Non Current AssetsCr
453394387345341315313380603389350
Total Assets
Total AssetsCr
1,3521,3231,3221,3311,3561,3161,4901,6491,8622,1282,361

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
38281056387033104-225-122
Investing Cash Flow
Investing Cash FlowCr
-21-236-2-276-13-32-1268-17
Financing Cash Flow
Financing Cash FlowCr
-26-16-24-26-34-72-22-4452774
Net Cash Flow
Net Cash FlowCr
-9-12-828-244-228-29100-66
Free Cash Flow
Free Cash FlowCr
369104535712363-21-12-118
CFO To PAT
CFO To PAT%
409.82,322.3214.91,067.194.4-174.192.7104.3-36.43.8-250.5
CFO To EBITDA
CFO To EBITDA%
108.8-405.5149.9794.169.6-523.5148.888.6-29.65.4-235.8
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
38281056387033104-225-122
Investing Cash Flow
Investing Cash FlowCr
-21-236-2-276-13-32-1268-17
Financing Cash Flow
Financing Cash FlowCr
-26-16-24-26-34-72-22-4452774
Net Cash Flow
Net Cash FlowCr
-9-12-828-244-228-29100-66
Free Cash Flow
Free Cash FlowCr
369104535712363-21-12-118
CFO To PAT
CFO To PAT%
409.82,322.3214.91,067.194.4-174.192.7104.3-36.43.8-250.5
CFO To EBITDA
CFO To EBITDA%
108.8-405.5149.9794.169.6-523.5148.888.6-29.65.4-235.8

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4026345792721333315125381,354840628728
Price To Earnings
Price To Earnings
47.1315.0100.840.13.414.55.520.36.512.825.1
Price To Sales
Price To Sales
0.71.31.10.50.30.70.80.51.80.80.70.8
Price To Book
Price To Book
0.61.00.90.40.20.50.60.61.40.80.60.6
EV To EBITDA
EV To EBITDA
16.7-120.9108.861.04.9-34.825.84.919.19.413.918.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
27.423.927.725.231.419.220.021.618.015.113.013.0
OPM
OPM%
5.9-1.41.21.410.3-2.63.411.59.98.15.55.1
NPM
NPM%
1.60.30.91.07.6-8.05.59.88.111.75.23.2
ROCE
ROCE%
5.33.93.53.46.4-1.46.711.17.213.05.65.6
ROE
ROE%
1.50.20.70.85.5-5.94.511.06.311.64.34.3
ROA
ROA%
0.70.10.30.42.9-3.12.46.03.35.92.12.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4026345792721333315125381,354840628728
Price To Earnings
Price To Earnings
47.1315.0100.840.13.414.55.520.36.512.825.1
Price To Sales
Price To Sales
0.71.31.10.50.30.70.80.51.80.80.70.8
Price To Book
Price To Book
0.61.00.90.40.20.50.60.61.40.80.60.6
EV To EBITDA
EV To EBITDA
16.7-120.9108.861.04.9-34.825.84.919.19.413.918.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
27.423.927.725.231.419.220.021.618.015.113.013.0
OPM
OPM%
5.9-1.41.21.410.3-2.63.411.59.98.15.55.1
NPM
NPM%
1.60.30.91.07.6-8.05.59.88.111.75.23.2
ROCE
ROCE%
5.33.93.53.46.4-1.46.711.17.213.05.65.6
ROE
ROE%
1.50.20.70.85.5-5.94.511.06.311.64.34.3
ROA
ROA%
0.70.10.30.42.9-3.12.46.03.35.92.12.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Vascon Engineers is fundamentally a builder - it constructs hospitals, colleges, police quarters and IT parks for government bodies and corporations, while also developing mid-market homes, all under one roof. Founded in 1986 with a factory for Cipla, the company has spent four decades turning a single EPC contract into an integrated operation that handles design, engineering and execution in-house, an approach it believes lets it charge a premium and control quality from blueprint to handover. That same in-house capability is what it brings to its own real estate projects, where it partners with landowners rather than buying land, keeping its own cash outlay low. # Business segments Two engines that feed each other - a government-heavy EPC contracting business that generates the bulk of activity, and an asset-light real estate arm that uses the same in-house construction muscle to build homes on other people’s land. ## 1. EPC: the government’s builder **Vascon wins large turnkey construction contracts, mostly from government bodies, and executes everything from design to delivery with its own team - collecting fees as work progresses.** - **Design-led bidding** - the company prefers to enter projects at the design or redesign stage, which lets it do its own engineering and showcase its skills rather than just competing on price alone. - **Government is the anchor client** - roughly 79% of the external order book comes from government-backed projects, which the company says brings timely payments and cash-flow stability because escalation clauses cover rising labour and material costs. - **In-house muscle** - over 500 skilled professionals handle architectural design, structural engineering and execution without relying on external agencies, an integrated turnkey approach that Vascon states allows it to command a premium over other construction companies. - **Order book gives two-to-three-year visibility** - as of December 31, 2025, the external EPC order book stood at Rs 2,387 crore, with marquee projects including a Government Medical College at Sindhudurg (Rs 279 crore), a Capgemini IT Park in Tamil Nadu (Rs 213 crore), and a hospital for Navi Mumbai Municipal Corporation (Rs 219 crore). - **A new partnership model** - in September 2025, Vascon signed a five-year memorandum with Adani Infra as an Execution Partner under an Early Engagement Model, moving away from traditional tenders; the collaboration targets about 13 million square feet of projects in Mumbai, with Vascon involved from the design stage. ## 2. Real Estate Development: building homes on other people’s land **Vascon develops mid-market and premium residential projects by partnering with landowners through joint ventures and development agreements, contributing its construction expertise rather than heavy upfront capital.** - **Asset-light, not land-heavy** - the company uses Joint Ventures and Joint Development Agreements with landowners that require low upfront deposits, so it minimises the capital tied up in land and deploys its own EPC team to build. - **Revenue only on completion** - unlike the EPC business, real estate revenue is recognised only when projects are finished, under the completed contract method, which means sales bookings and collections build up on the balance sheet before they hit the income statement. - **Four projects on the go** - ongoing developments include Tulip Phase III in Coimbatore (a joint development, 74% sold), Tower of Ascend, a commercial project in Pune (73% sold), GoodLife value housing in Talegaon (83% sold), and Orchids, a luxury redevelopment in Mumbai’s Santacruz with an expected gross development value of Rs 300 crore. - **A pipeline worth over Rs 1,100 crore** - near-term launches include a joint venture residential project in Powai, Mumbai, and the Prakash Housing Society redevelopment in Santacruz, with a combined attributable saleable area of 0.82 million square feet and expected sales value of Rs 1,110 crore for Vascon. # Group structure and partners **Vascon has simplified its group structure by selling non-core subsidiaries, while building a strategic partnership with Adani Infra and maintaining relationships with a consortium of lenders.** - **Exited the clean-room business** - in October 2024, Vascon sold its 100% subsidiary GMP Technical Solutions, a manufacturer of clean room partitioning systems, to Shinryo Corporation for Rs 157.36 crore, exiting a non-core backward-integration venture. - **Cleaned up dormant subsidiaries** - in March 2025, the company divested two wholly owned subsidiaries with nil turnover, Marathawada Realtors and Almet Corporation, further streamlining the group. - **Adani as a strategic partner** - the five-year Early Engagement Model with Adani Infra, signed in September 2025, positions Vascon as a selected execution partner on roughly 13 million square feet of Mumbai projects, a shift from the traditional tender-based model. - **Lender backing** - the company has a consortium of lenders including SBI, ICICI, and Tata Capital, and during FY26 SBI improved working capital terms by reducing collateral coverage from 35% to 27% and cutting bank guarantee margins on longer-tenure guarantees.

Documents — Vascon Engineers Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/n3l0r5b6k494mp8s6c8b7a30.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/2x9sbyub755pg12i99tjbxmf.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/fd34hm0agtd30uvqkwgma1g0.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/j7cbm5zxixpz8u256mcwne0o.pdf
  • Q1 FY2025 Earnings Call Transcript (Jun 2024, PDF): https://www.stockscans.in/document/yq8khz4vu22s8nflxbgd2z17.pdf
  • Q4 FY2024 Earnings Call Transcript (Mar 2024, PDF): https://www.stockscans.in/document/f8rdj3cn1d9spfaosrn2kq9l.pdf
  • Q3 FY2021 Earnings Call Transcript (Dec 2020, PDF): https://www.stockscans.in/document/veb4kp3wy51ophcosh8mveat.pdf
  • Q2 FY2021 Earnings Call Transcript (Sep 2020, PDF): https://www.stockscans.in/document/ftbf5bzsyqgm8283bblpefr8.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/mgun08ipd1c8sc6xe5o66er4.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/s8k17flgp838isi0kmw080ao.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/j9kmkl8deljjbsesonwwm00z.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/imf9s8017brqhbxtdmqa7tsj.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/lir3q7eskuv6l0r5btjak6ts.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/1fuxg6mpid78yd8c6etjkeab.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/zkhgogthv0izqbvfrpnqmqmz.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/594d7nidu751nlzdg8zxbtkj.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/nurmcasxrlgliybhnizhp5xf.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/yja9mmf0cxqwfn3e9xaedlal.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/e9ocxcvm0xdg081oc2oftepl.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/aj0wbzeaq04fvmeoa9bzc9zx.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/wga5mlyisw6ct5uoal0v4jjp.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/2uds4h6wjlg2jyy5ty5bvirh.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/je4a6d0w7zd2a67aonjjgapp.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/gvw4blkzxh5w8pgo5e8n4rm8.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/vngl1ycei998ay9na74uo4ho.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/g23e820vl1ioxzqyramvh5xi.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/rylqs79dtkcxftpognbiibbo.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/uxu2zwefo4065utcjps5beaf.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/dilt7yo01wzrcv3yh7xe1a0k.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/a4skm374hy6t53cqnp06hz19.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/nhfjwqitbgovi9aavs3onw1x.pdf

Concall Transcript Summaries — Vascon Engineers Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AVASCONEQ/transcript-notes/202606/n3l0r5b6k494mp8s6c8b7a30.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AVASCONEQ/transcript-notes/202512/2x9sbyub755pg12i99tjbxmf.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AVASCONEQ/transcript-notes/202509/fd34hm0agtd30uvqkwgma1g0.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AVASCONEQ/transcript-notes/202409/j7cbm5zxixpz8u256mcwne0o.pdf
  • Q1 FY2025 Concall Transcript Summary (Jun 2024): https://www.stockscans.in/company/NSE%3AVASCONEQ/transcript-notes/202406/yq8khz4vu22s8nflxbgd2z17.pdf
  • Q4 FY2024 Concall Transcript Summary (Mar 2024): https://www.stockscans.in/company/NSE%3AVASCONEQ/transcript-notes/202403/f8rdj3cn1d9spfaosrn2kq9l.pdf